Medicine
L. Zuur, A. Jansen, S. van der Graaf, K. de Bie, E. Schaake, F. Pos, A. Vis, H. van der Poel, W. Vogel, P. van Leeuwen
Abstract
Highlights • PSMA-PET/CT-guided sWPRT post-RP gave high 5-yr biochemical and metastasis-free survival (69.3% & 79.0%).• Biochemical progression occurred in 25%; in-field nodal recurrences were rare.• Treatment was associated with favourable toxicity.• Supports PSMA-PET/CT-guided sWPRT with ADT as an effective salvage strategy for nodal recurrence post-RP.
Citation format
ZUUR, L., et al. Oncological outcomes following PSMA pet/ct-guided salvage whole-pelvis radiotherapy for recurrent prostate cancer. Clinical and Translational Radiation Oncology, 2026, 59: 101161.